Lupus Research Alliance News
LRA-Supported Study Confirms Two Targets for Drugs in Development

October 1, 2020 In a recent Lupus Research Alliance supported study published in Frontiers in Immunology, Dr. Ziaur Rahman linked molecules called TLR7 and type II interferon to impairing the ability of immune cells to do their job. These findings support further development by several companies of lupus treatments that block TLR7 and type II […] READ MORE

Lupus Clinical Trials Redefined: You Make the Difference

Lupus Clinical Trials Redefined: You Make the Difference Lupus Clinical Trials Virtual Fair October 17, 2020 10:00 am to 1:00 pm ET Register Here Lupus clinical trials are still underway despite COVID-19. Making the process safer and easier for patients has never been more important. What is a clinical trial exactly? Why should I get involved […] READ MORE

LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis

September 16, 2020 NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s New England Journal of Medicine, demonstrating that GSK’s drug Benlysta® (belimumab) significantly improved kidney function in adults with lupus nephritis, the most common severe complication of lupus causing inflammation and serious damage to the kidney. The […] READ MORE

Lupus Therapeutics Collaborating with PPD to Accelerate Lupus Clinical Research

September 3, 2020 PPD, Inc. issued a press release  today announcing its collaboration with the Lupus Research Alliance affiliate Lupus Therapeutics to optimize lupus clinical research among its pharmaceutical and biotech clients. As a contract research organization, PPD helps its clients design and implement clinical trials. PPD expects to gain from Lupus Therapeutics’ deep clinical […] READ MORE

23andMe Study Confirms Lupus Can Run in Families and Other New Insights

August 25, 2020 A study started four years ago and conducted by 23andMe provided many insights about lupus as a complex disease that is extremely difficult to diagnose and treat. While the survey of nearly 6,000 participants did not find new genetic factors causing lupus as hoped, the study confirmed that lupus can run in […] READ MORE

Family Night with GoGo squeeZ

Go Go with Us for Family Fun Night August 26!  Enjoy a light-hearted demonstration of a nutritious kid-friendly recipe, celebrate fundraising successes with outstanding Walk Team Captains and hear an insider preview of the first and largest virtual lupus Walk Event September 12. EVENT DATE | TIME  August 26, 7:00 PM Eastern Time  PROGRAM Welcome […] READ MORE

Watch Webcast Video: Redefining Lupus Trials Amid COVID-19 and Beyond

Videotape of 8.24.20 Learn from Lupus Zoom Webcast Ensuring the clinical trial process is accommodating for participants has always been the goal. However, COVID-19 has forced industry, research organizations, doctors, and patients to think twice about the process and its impact on high-risk populations including people with lupus who are immunocompromised. In light of COVID-19, […] READ MORE

LRA-Supported Study Discovers How Harmful Immune Cells Develop

August 17, 2020 In a new study published in the journal Immunity, Lupus Research Alliance-funded researcher Dr. Boris Reizis and his colleagues identified conditions under which immune cells called B cells begin to attack healthy genetic material (DNA). Dr. Reizis’ findings highlight the potential of drugs such as anifrolumab and BIIB-059 as potential treatments for […] READ MORE

LRA Proudly Congratulates Dr. Lindsey Criswell on NIAMS Appointment

August 13, 2020 The Lupus Research Alliance is proud to congratulate one of our funded researchers, Lindsey A. Criswell, MD, MPH, DSc, on her new appointment as Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Currently Vice Chancellor of Research at the University of California, San Francisco, Dr. Criswell has […] READ MORE

Learn and connect with our community!